Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03820830
Title Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer (POLAR)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors International Breast Cancer Study Group
Age Groups: adult | senior
Covered Countries ITA | FRA | ESP | AUT

No variant requirements are available.